A way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The scientific efforts led by Salvemini, who is professor of pharmacological and physiological sciences at SLU, demonstrated that turning on a receptor in the brain and spinal cord counteracts chronic nerve pain in male and female rodents. Activating the A3 receptor – either by its native chemical stimulator, the small molecule adenosine, or by powerful synthetic small molecule drugs invented at the NIH – prevents or reverses pain that develops slowly from nerve damage without causing analgesic tolerance or intrinsic reward (unlike opioids).
An Unmet Medical Need
Pain is an enormous problem. As an unmet medical need, pain causes suffering and comes with a multi-billion dollar societal cost. Current treatments are problematic because they cause intolerable side effects, diminish quality of life and do not sufficiently quell pain.
The most successful pharmacological approaches for the treatment of chronic pain rely on certain “pathways”: circuits involving opioid, adrenergic, and calcium channels.
For the past decade, scientists have tried to take advantage of these known pathways – the series of interactions between molecular-level components that lead to pain. While adenosine had shown potential for pain-killing in humans, researchers had not yet successfully leveraged this particular pain pathway because the targeted receptors engaged many side effects.
A Key to Pain Relief
In this research, Salvemini and colleagues have demonstrated that activation of the A3 adenosine receptor subtype is key in mediating the pain relieving effects of adenosine.
“It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain,” Salvemini said. “Our findings suggest that this goal may be achieved by focusing future work on the A3AR pathway, in particular, as its activation provides robust pain reduction across several types of pain.”
The Latest on: Pain relief
via Google News
The Latest on: Pain relief
- Aurora Spine jumps 8% after launching new pain care division for chronic back painon November 30, 2020 at 8:33 am
(OTCPK:AROSF) launched a new Pain Care Division designed to focus on the rapidly growing segment of pain care using mechanical devices such as the ZIP and SiLO.The ZIP Screwless Fusion Procedure for ...
- Managing Chronic Painon November 30, 2020 at 7:43 am
Dr. Hui Kang with Northwest Anesthesiology and Pain Services explains how they can help you live pain free from various causes of chronic pain.
- Back pain sufferer, 30, died from accidentally overdosing on morphine after computer labelling error on prescription drug bottle, inquest hearson November 30, 2020 at 5:25 am
Hamish Hardie, 30, from Billingshurst, West Sussex, accidentally overdosed on morphine after a computer error meant the exact dosage he was supposed to take was not clearly marked.
- $150+ Billion Chronic Pain Treatment Market - Global Industry Analysis and Growth Forecast to 2030 - ResearchAndMarkets.comon November 27, 2020 at 10:59 am
The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate a revenue of $151.7 billion in 2030. The factors fueling the expansion of the market ...
- 6 breathing exercises for pain reliefon November 27, 2020 at 3:22 am
The benefits of deep breathing for pain relief are two-fold. ‘When experiencing pain, muscles tend to contract as a protective mechanism, as well as potential tightening in the tissues that have ...
- Elixicure All Natural Pain Relief Launches Streamlined New Packagingon November 24, 2020 at 10:12 am
Elixicure, the industry leader for natural pain relief sports cream has updated packaging for its all natural plant-based products. The same trusted formula is now available in new packaging across ...
- All About Joint Pain During Pregnancy (and Getting Relief)on November 23, 2020 at 5:54 pm
Pregnancy causes all types of aches and pains in your body. That’s why it’s not uncommon to see many of us sporting the infamous “hand on lower back” position. And while joint pain can happen anywhere ...
- Back Pain Wizard Customer Review: Get Lower Back Pain Reliefon November 23, 2020 at 1:00 am
What Does The Back Pain Wizard Involve? The Back Pain Wizard is not only a presentation of physical exercises that anyone can perform on their own to get rid of back pain. It's a way of life, yet not ...
- Global Pain Relief Patches Market by Size, Growth, Opportunity and Forecast to 2025on November 20, 2020 at 7:58 am
Selbyville, Delaware, Global Pain Relief Patches Market report added by Market Study Report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, ...
- 7 CBD and Hemp Products That Do Wonders for Pain Reliefon November 19, 2020 at 9:18 pm
These CBD and Hemp-infused products from EdenPURE promise to improve or even cure body pains without any negative side effects.
via Bing News